The Enterprise Value as of June 2026 (TTM) for Radiopharm Theranostics Limited (RADX) is 12.78M

According to Radiopharm Theranostics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 12.78M. This represents a change of 14.98% compared to the average of 11.12M of the last 4 quarters.

Radiopharm Theranostics Limited (RADX) Historical Enterprise Value (quarterly & annually)

How has RADX Enterprise Value performed in the past?

The mean historical Enterprise Value of Radiopharm Theranostics Limited over the last ten years is 28.20M. The current 12.78M Enterprise Value has changed 4.43% with respect to the historical average. Over the past ten years (40 quarters), RADX's Enterprise Value was at its highest in in the June 2021 quarter at 99.03M. The Enterprise Value was at its lowest in in the December 2024 quarter at -27161848.90.

Radiopharm Theranostics Limited (RADX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Radiopharm Theranostics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Radiopharm Theranostics Limited (RADX) Average Enterprise Value

How has RADX Enterprise Value performed in the past?

The current Enterprise Value of Radiopharm Theranostics Limited (RADX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Radiopharm Theranostics Limited (RADX) Enterprise Value vs. Peers

How is RADX’s Enterprise Value compared to its peers?

Radiopharm Theranostics Limited’s Enterprise Value is greater than Alaunos Therapeutics, Inc. (5.17M), greater than Impact BioMedical Inc. (7.29M), greater than Quoin Pharmaceuticals, Ltd. (5.31M), greater than NovaBay Pharmaceuticals, Inc. (9.62M), greater than Brainstorm Cell Therapeutics Inc. (9.75M), greater than Cardio Diagnostics Holdings, Inc. (-2485596.00), greater than Addex Therapeutics Ltd (4.62M), greater than Matinas BioPharma Holdings, Inc. (3.07M), greater than Pasithea Therapeutics Corp. (-46001320.00), greater than Cyclerion Therapeutics, Inc. (11.25M),

Build a custom stock screener for Radiopharm Theranostics Limited (RADX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Radiopharm Theranostics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Radiopharm Theranostics Limited (RADX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Radiopharm Theranostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.